7-CPP,
antagonist SRIF-A,
CyCam,
cyclo(7-Ahep-Phe-Trp-Lys-Thr(Bzl)),
cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),
cyclo-(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr(Bzl)),
CyCam,
Cyclosomatostatin,
Antagonist srif-A,
cyclo-SOMATOSTATIN,
CPP1,
7-CPP,
84211-54-1,
Cyclo(7-ahep-phe-trp-lys-thr(bzl)),
Cyclo-(7-ahep-phe-trp-lys-bzl-thr)-somatostatin,
Cyclo-(7-aminoheptanoyl-phe-D-trp-lys-thr(bzl)),
somatostatin, cyclo-(7-Ahep-Phe-Trp-Lys-Bzl-Thr)-,
Cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl),
Cyclo-(7-aminoheptanoyl-phenylalanyl-tryptophyl-lysyl-benzylthreonyl)-somatostatin,
Somatostatin, cyclo-(7-aminoheptanoyl-phenylalanyl-tryptophyl-lysyl-benzylthreonyl)-,
L-Threonine, N-(7-amino-1-oxoheptyl)-L-phenylalanyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-, (2S-(1(R*(R*)),2alpha,3abeta,7abeta))-,
(3s,6s,9r,12s)-6-(4-aminobutyl)-12-benzyl-3-[(1r)-1-(benzyloxy)ethyl]-9-(1h-indol-3-ylmethyl)-1,4,7,10,13-pentaazacycloicosane-2,5,8,11,14-pentone,
Cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[Bzl]),
AC1L3TXM,
CTK8E0373,
MFCD00076778,
ZINC95670552,
AKOS024457638,
LS-186817,
LS-187484,
FT-0772936,
C-54763,
Cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[Bzl]), >=95% (HPLC), powder,
(3S,6S,9R,12S)-6-(4-aminobutyl)-12-benzyl-9-(1H-indol-3-ylmethyl)-3-[(1R)-1-phenylmethoxyethyl]-1,4,7,10,13-pentazacycloicosane-2,5,8,11,14-pentone,
(3S,6S,9R,12S)-9-((1H-indol-3-yl)methyl)-6-(4-aminobutyl)-12-benzyl-3-((R)-1-(benzyloxy)ethyl)-1,4,7,10,13-pentaazacycloicosane-2,5,8,11,14-pentaone,
CYCLO,
C15H13Cl2N3S,
C44H57N7O6,
KST-1A8777,
C15-H13-Cl2-N3-S,
AR-1A4656,
CID122080,
C44-H57-N7-O6,
89985-01-3,
N-(2,4-Dichlorophenyl)-N-(4,5-dihydro-2-thiazolyl)-3-pyridinemethanamine,
3-Pyridinemethanamine, N-(2,4-dichlorophenyl)-N-(4,5-dihydro-2-thiazolyl)-,